Survival analysis of early-stage breast cancer patients undergoing axillary lymph node dissection and sentinel lymph node dissection

SLND is a safe and effective alternative to ALND in BC patients with limited nodal involvement. This study provides additional evidence that the findings of ACOSOG Z0011 are applicable to the larger early-stage BC population.